Clinical Trial Update: Phase I/II Trial of S65487 Plus Azacitidine in Acute Myeloid Leukemia [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II clinical trial evaluating S65487 plus azacitidine for Acute Myeloid Leukemia; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• S65487

Snippet

Sponsor: Institut de Recherches Internationales Servier | Conditions: Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING